Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.37 |
| ▸ | RRM1 | P23921 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.33 |
| ▸ | GSR | P00390 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30860145 | 1.00 | NOS1 (0.40) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL30471715 | 1.00 | NOS1 (0.40) | NOS1NOS3NOS2LTA4HDPP7 | |
| Hydrochloric Acid SCHEMBL5821232 | 0.98 | NOS1 (0.39) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL3294154 | 0.89 | NOS1 (0.42) | NOS1NOS3NOS2LTA4HMEN1 | |
| SCHEMBL11415214 | 0.88 | GSR (0.44) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL11415211 | 0.88 | GSR (0.44) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL855007 | 0.88 | GSR (0.44) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL855342 | 0.86 | GSR (0.52) | NOS1NOS3NOS2LTA4HDPP7 | |
| Hydrochloric Acid SCHEMBL11272393 | 0.86 | GSR (0.42) | NOS1NOS3NOS2LTA4HDPP7 | |
| SCHEMBL866977 | 0.86 | GSR (0.52) | NOS1NOS3NOS2LTA4HDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024221952-A1 | NANO-DELIVERY SYSTEM OF NUCLEOTIDE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-10-31 | — | — | WO | claimed |
| CN-106750252-B | Distearoylphosphatidylethanolamine-polyethylene glycol 2000- double leaf acid and its preparation method and application | 山东大学齐鲁医院 | 2018-11-30 | — | — | CN | claimed |
| CN-106750252-A | DSPE polyethylene glycol 2000 double leaf acid and its preparation method and application | 山东大学齐鲁医院 | 2017-05-31 | — | — | CN | claimed |
| EP-1532444-A2 | METHOD FOR ANALYZING BODY FLUIDS FOR THE PRESENCE OF CANCER CELLS AND CORRESPONDING ANALYSIS KITS | Giesing, Michael, Prof. Dr. med. (DE) | 2005-05-25 | — | — | EP | claimed |
| WO-2004019037-A2 | METHOD FOR ANALYZING BODY FLUIDS FOR THE PRESENCE OF CANCER CELLS, USE THEREOF, CORRESPONDING ANALYSIS KITS, AND USE OF SPECIFIC ACTIVE SUBSTANCES FOR TREATING CANCER | GIESING MICHAEL (DE) | 2004-03-04 | — | — | WO | claimed |
| CN-122080114-A | Composition containing long-chain alkane for polypeptide synthesis and preparation method of polypeptide | — | 2026-05-26 | — | — | CN | disclosed |
| US-20250387492-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | FUSION PHARMACEUTICALS INC (CA) | 2025-12-25 | — | — | US | disclosed |
| US-20250353872-A1 | Ligand-Modified Oligonucleotides | NOVO NORDISK A/S (DK) | 2025-11-20 | — | — | US | disclosed |
| EP-4572758-A1 | PROTEIN:PROTEIN INTERACTION INHIBITORS | Purdue Research Foundation (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119859122-B | Tyrosinase inhibitor and preparation method and application thereof | 杭州师范大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119859122-A | Tyrosinase inhibitor and preparation method and application thereof | 杭州师范大学 | 2025-04-22 | — | — | CN | disclosed |
| EP-4526303-A1 | N6-ADENOSINE-METHYLTRANSFERASE PROTACS AND METHODS OF USE THEREOF | University of Zurich (CH) | 2025-03-26 | — | — | EP | disclosed |
| WO-2001016162-A1 | METHOD FOR PRODUCING CYCLIC PEPTIDOMIMETICS | CHEMOTOPIX GMBH (DE) | 2001-03-08 | — | — | WO | disclosed |
| WO-1999050244-A9 | NITROXIDE FREE RADICAL DUAL INDICATOR AGENTS | LIPITEK INC (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999050244-A1 | NITROXIDE FREE RADICAL DUAL INDICATOR AGENTS | LIPITEK, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| EP-0938497-A1 | CONSTRAINED HELICAL PEPTIDES AND METHODS OF MAKING SAME | Genentech, Inc. (US) | 1999-09-01 | — | — | EP | disclosed |
| EP-0874841-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR B2 ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1998-11-04 | — | — | EP | disclosed |
| WO-1998020036-A1 | CONSTRAINED HELICAL PEPTIDES AND METHODS OF MAKING SAME | GENENTECH, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| WO-1997024349-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1997-07-10 | — | — | WO | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353872-A1 | Ligand-Modified Oligonucleotides | NCL, ADAR, NSUN3 | NOS1 4148/4885NOS3 3687/4885NOS2 4166/4885 |
| US-20250387492-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90AB2P, HSP90AA1 | NOS1 3589/4885NOS3 2871/4885NOS2 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.